Oncology
2 drugs are in development for Colorectal Neoplasms.
- Companies
- 2
- Clinical trials
- 37
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Colorectal Neoplasms pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| zaltrap | Sanofi (SNY) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| tc-510 | TCR2 THERAPEUTICS INC. (TCRR) |
About this indication
Colorectal Neoplasms context
Oncology·MeSH: Colorectal Neoplasms (D015179)
Also known as: Colorectal Neoplasm, Colorectal Tumor, Tumors, Colorectal
Narrower concepts tracked separately: Colorectal Cancer (CRC), Colorectal Carcinoma, Colorectal Cancer
Prevalence
135.0 / 100K
Incidence
36.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Colorectal Neoplasms?
BioSniper tracks 2 drugs in development for Colorectal Neoplasms across 2 companies.
How many clinical trials target Colorectal Neoplasms?
There are 37 clinical trials targeting Colorectal Neoplasms tracked by BioSniper.
What is the prevalence of Colorectal Neoplasms?
The estimated prevalence of Colorectal Neoplasms is approximately 135.0 per 100,000 population.